PATENT CLAIM ANALYSIS

Application Number: 15983269
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "326000"]

Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.

Claim (Index 4):
The compound or salt according to  claim 2  wherein the compound is N-[4-fluoro-5-[[(2S,4S)-2-methyl-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methoxy]-1 piperidyl]methyl]thiazol-2-yl]acetamide.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15874947', '13501587', '13883788', '13296384', '15520462']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7851370176413458
- 35 USC 102 Novelty (BERT): 0.523289963277726
- Combined Prediction Score: 0.7589523122049839
- Mean Citation Score: 279.766168
- Max Citation Score: 340.1373
- Similarity Product: 331.67420012399555

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test